ForumIAS LATEST
- 24 May |UPSC Prelims 2026 Paper Solved LIVE | GS Paper Detailed Discussion | ForumIAS Click Here →
- 17 May | ABC of Indian Sociology Series | 'H' = HAROLD COULD | Sociology Optional Simplified Click Here →
- 15 May | If You Are Giving Prelims 2026, Watch This Before Entering the Exam Hall Click Here to listen to Ayush Sir's advice →
News: India has started the clinical trials of Covid-19 vaccine – ZyCoV-D.
Facts:
- ZyCoV-D: It is a plasmid DNA vaccine designed and developed by Zydus, a pharmaceutical company.
- The vaccine comes under the Vaccine Discovery Programme supported by the Department of Biotechnology under the National Biopharma Mission.
Additional Facts:
- National Biopharma Mission(NBM): It is an Academia-Industry Collaborative Mission for Accelerating Discovery Research to Early Development for Biopharmaceuticals.
- Launched Year: It was launched in 2017 at a total cost of Rs 1500 crore and is 50% co-funded by World Bank loan.
- Objective: To enable and nurture an ecosystem for preparing India’s technological development capabilities in biopharmaceuticals including vaccines, medical devices and diagnostics to a level that will be globally competitive over the next decade.
- Implementation: Biotechnology Industry Research Assistance Council (BIRAC).
- Innovate in India(i3) Programme: Under this Mission, the Government has launched Innovate in India(i3) programme to create an enabling ecosystem to promote entrepreneurship and indigenous manufacturing in the biopharma sector.
